Home » Topics » Regulatory

Regulatory
RSS

Ganovo approved in China for hepatitis C

June 13, 2018

FDA approves Rituxan for moderate to severe pemphigus vulgaris

June 11, 2018

FDA approves pegfilgrastim biosimilar Fulphila

June 5, 2018

FDA approves Consensi for osteoarthritis pain and hypertension

June 4, 2018

FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause

May 30, 2018

European Commission grants authorization to Rubraca for recurrent ovarian cancer

May 30, 2018

FDA approves Cimzia for the treatment of adults with moderate to severe plaque psoriasis

May 29, 2018

FDA approves Palynziq for adults with phenylketonuria

May 25, 2018

Prolia approved in U.S. for glucocorticoid-induced osteoporosis

May 22, 2018

FDA approves thrombopoietin receptor agonist Doptelet

May 22, 2018

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...